Kyle Piskel - 18 May 2026 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
20 May 2026, 19:13:43 UTC
Prior SEC filing
13 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kyle Piskel

Key filing fact

Kyle Piskel filed Form 4 for Adaptive Biotechnologies Corp (ADPT) on 20 May 2026.

Key facts

  • This page summarizes Kyle Piskel's Form 4 filing for Adaptive Biotechnologies Corp (ADPT).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 20 May 2026, 19:13.

Change

  • Previous filing in this sequence was filed on 13 Mar 2026.
  • Current net transaction value: -$40,620.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001780662 Primary reporting owner

PISKEL KYLE

Relationship
Chief Financial Officer
Address
C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION, 1165 EASTLAKE AVENUE EAST, SEATTLE
Signature
/s/ Kyle Piskel
Signature date
20 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ADPT transaction

Common Stock

Sale

Transaction value
$40,620
Shares
-3,115
Change %
-1.2%
Price
$13.04
Shares after
256,725
Date
18 May 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .